Credit: PROFESSOR JOHN ZAJICEK/Science Source
And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.
The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.
Walk with us.
With studies lacking, expert opinion leads guidance for DMT therapy in MS during the COVID-19 pandemic
As the COVID-19 pandemic remains steadfast, medical communities continue seeking updated guidance on how the outbreak affects their respective patient populations, and multiple sclerosis (MS) is no exception.
Exercising the mind through cognitive rehabilitation is now a recommended intervention for the many individuals with multiple sclerosis (MS) who experience difficulties with memory, thinking, and other brain functions. Could exercising the body be too far behind?
More than 4 months after it was established, the COViMS (COVID-19 Infections in Multiple Sclerosis and Related Diseases) database includes information about nearly 900 patients. The Consortium of Multiple Sclerosis Centers (CMSC) and the National Multiple Sclerosis Society (NMSS) initiated the database in April to gather information about COVID-19 infections and outcomes in North American patients with multiple sclerosis (MS) and other CNS demyelinating disorders.
Comorbidities are common in patients with multiple sclerosis (MS), can impact treatment decisions, and require a multidisciplinary approach to management, including careful attention to lifestyle issues, said Patricia Melville, RN, MSN, NP-C, MSCN, in a presentation at the virtual annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC).
For individuals with multiple sclerosis the experience of aging appears to follow along one of two paths – some people feel their preexisting disability gives them an advantage in coping and tolerating age-related difficulties, while others feel more acutely the double burdens of MS and aging.